http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
XXXII, 791 p. 44 illus., 6 illus. in color. online resource.
This book is an essential guide to the medical treatment of the cardiac patient and presents core principles of cardiovascular therapeutics as well as drug recommendations. Major classes of drugs are featured, including beta-blockers, ACE inhibitors, calcium antagonists, diuretics, and antiplatelet agents and unique insights into the controversies surrounding the use of specific drugs are explored, with answers given to the question: do beta blockers and diuretics really cause diabetes? Properties, dosage, side effects, potential salutary benefits, and drawbacks on virtually all commercially available cardiac drugs are examined. This revised edition is thoroughly updated and addresses the entire spectrum of heart disorders, such as hypertension, angina, myocardial infarction, heart failure, arrhythmias, cardiac arrest, and dyslipidemias. New chapters include endocrine heart diseases, management of cardiomyopathies, and newer agents. In addition, topics such as cardiac drugs in pregnancy and lactation and drug interactions are covered. Cardiac Drug Therapy, Eighth Edition, is an authoritative and clinically relevant resource for cardiologists, cardiology fellows, and internists.
Beta-Blockers: The Cornerstone of Cardiac Drug Therapy -- Beta-Blocker Controversies -- Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers -- ACE Inhibitor Controversies -- Calcium Antagonists (Calcium Channel Blockers) -- Calcium Antagonist Controversies -- Diuretics -- Hypertension -- Hypertension Controversies -- Angina -- Acute Myocardial Infarction -- Heart Failure -- Heart Failure Controversies -- Management of Cardiac Arrhythmias -- Cardiac Arrest -- Management of Infective Endocarditis -- Dyslipidemias -- Endocrine Heart Diseases -- Antiplatelet Agents, Anticoagulants, Factor XA Inhibitors, Thrombin Inhibitors -- Cardiac Drugs During Pregnancy and Lactation -- Effects of Drug Interactions -- Hallmark Clinical Trials -- Management of Cardiomyopathies -- Newer Agents.